Cardiovascular risk assessment for osteoporosis patients considering Romosozumab

F Macrae*, E M Clark, K Walsh, S J Bailey, M Roy, S Hardcastle, C Cockill, J H Tobias, B G Faber

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

2 Citations (Scopus)
36 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cardiovascular risk assessment for osteoporosis patients considering Romosozumab'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science